Old Web
English
Sign In
Acemap
>
Paper
>
Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma
Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma
2018
John A Heath
Marty A Campbell
Alison Thomas
Ben Solomon
Keywords:
Intensive care medicine
Neuroblastoma
Cancer research
Alectinib
Medicine
ALK inhibitor
Pathology
Refractory
Correction
Source
Cite
Save
Machine Reading By IdeaReader
7
References
13
Citations
NaN
KQI
[]